Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease

Nephrology

Volumn 17, Issue 6, 2012, Pages 575-581

  Yadav, Ashok Kumar ^a   Banerjee, Debasish ^b   Lal, Anupam ^a   Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

atherosclerosis; chronic kidney disease; intima media thickness; T cells; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CD28 ANTIGEN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; ULTRASOUND; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ANTIGENS, CD28; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84864450598     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01611.x     Document Type: Article

References (37)

1. Stevens PE, O'Donoghue DJ, de Lusignan S, et al,. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007; 72: 92-9. (Pubitemid 47014451)
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296-305.
3. Arici M, Walls J,. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int. 2001; 59: 407-14. (Pubitemid 32157905)
4. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J,. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. Suppl. 2008; 111: S4-9.
5. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM,. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62: 1524-38. (Pubitemid 35286260)
6. Menon V, Gul A, Sarnak MJ,. Cardiovascular risk factors in chronic kidney disease. Kidney Int. 2005; 68: 1413-18. (Pubitemid 43169885)
7. Dobnig H, Pilz S, Scharnagl H, et al,. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008; 168: 1340-49. (Pubitemid 351930842)
8. Martins D, Wolf M, Pan D, et al,. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2007; 167: 1159-65. (Pubitemid 46919818)
9. Mehrotra R, Kermah DA, Salusky IB, et al,. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009; 76: 977-83.
10. Ravani P, Malberti F, Tripepi G, et al,. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75: 88-95.
11. Wolf M, Shah A, Gutierrez O, et al,. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007; 72: 1004-13. (Pubitemid 47530570)
12. Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD,. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am. J. Med. 2010; 123: 335-41.
13. London GM, Guerin AP, Verbeke FH, et al,. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 2007; 18: 613-20. (Pubitemid 46193327)
14. Targher G, Bertolini L, Padovani R, et al,. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. (Oxf.) 2006; 65: 593-7. (Pubitemid 44583818)
15. London GM, Marchais SJ, Guerin AP, Metivier F,. Impairment of arterial function in chronic renal disease: Prognostic impact and therapeutic approach. Nephrol. Dial. Transplant. 2002; 17 (Suppl 11): 13-15. (Pubitemid 35277056)
16. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN,. Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000; 83: 205-9. (Pubitemid 30305552)
17. Autier P, Gandini S,. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007; 167: 1730-37. (Pubitemid 47403059)
18. Jeffery LE, Burke F, Mura M, et al,. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 2009; 183: 5458-67.
19. Bouillon R, Carmeliet G, Verlinden L, et al,. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr. Rev. 2008; 29: 726-76.
20. Gerli R, Schillaci G, Giordano A, et al,. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109: 2744-8. (Pubitemid 38737922)
21. Liuzzo G, Kopecky SL, Frye RL, et al,. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999; 100: 2135-9.
22. Nakajima T, Schulte S, Warrington KJ, et al,. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105: 570-75. (Pubitemid 34123430)
23. Betjes MG, Huisman M, Weimar W, Litjens NH,. Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int. 2008; 74: 760-67.
24. Yadav AK, Jha V,. CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrol. Dial. Transplant. 2011; 26: 1689-94.
25. Mahon BD, Wittke A, Weaver V, Cantorna MT,. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 2003; 89: 922-32. (Pubitemid 36927724)
26. Ross AC, Judd S, Kumari M, et al,. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir. Ther. 2011; 16: 555-63.
27. Garcia-Canton C, Bosch E, Ramirez A, et al,. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol. Dial. Transplant. 2011; 26: 2250-56.
28. Jabbar Z, Aggarwal PK, Chandel N, et al,. High prevalence of vitamin D deficiency in north Indian adults is exacerbated in those with chronic kidney disease. Nephrology (Carlton) 2009; 14: 345-9.
29. Peterson CA, Heffernan ME,. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J. Inflamm. (Lond.) 2008; 5: 10.
30. Suzuki Y, Ichiyama T, Ohsaki A, Hasegawa S, Shiraishi M, Furukawa S,. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J. Steroid Biochem. Mol. Biol. 2009; 113: 134-8.
31. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS,. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J. Am. Soc. Nephrol. 2009; 20: 1805-12.
32. Liuzzo G, Biasucci LM, Trotta G, et al,. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J. Am. Coll. Cardiol. 2007; 50: 1450-58. (Pubitemid 47494592)
33. Betjes MG, de Wit EE, Weimar W, Litjens NH,. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol. Dial. Transplant. 2010; 25: 3640-46.
34. Liuzzo G, Goronzy JJ, Yang H, et al,. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-8. (Pubitemid 30415876)
35. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM,. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J. Exp. Med. 2006; 203: 239-50. (Pubitemid 43139661)
36. Cantorna MT, Yu S, Bruce D,. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Aspects Med. 2008; 29: 369-75.
37. Smolders J, Thewissen M, Peelen E, et al,. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009; 4: e6635.